Dr. Anton Lishmanov, M.D., PHD
What this data tells you about Dr. Lishmanov
Dr. Anton Lishmanov is an internal medicine in Hudson, FL, with 16 years in practice. Based on federal Medicare data, Dr. Lishmanov performed 1,832 Medicare services across 1,302 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lishmanov received a total of $22,752 from 43 pharmaceutical and/or device companies across 338 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lishmanov is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 376 | $101 | $255 |
| Electrocardiogram (EKG), 12-lead | 286 | $11 | $30 |
| Hospital follow-up visit, high complexity | 209 | $96 | $236 |
| Hospital follow-up visit, moderate complexity | 175 | $64 | $158 |
| Initial hospital admission, high complexity | 117 | $139 | $360 |
| Echocardiogram, transthoracic | 90 | $151 | $380 |
| Regadenoson injection (Lexiscan) for heart stress test | 72 | $38 | $110 |
| Ultrasound of heart, follow-up | 66 | $20 | $50 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 54 | $329 | $522 |
| Cardiac catheterization | 35 | $207 | $888 |
| New patient office visit (45-59 min) | 34 | $134 | $335 |
| 3d radiographic procedure | 33 | $8 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 28 | $49 | $140 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 27 | $340 | $845 |
| Initial hospital admission, moderate complexity | 23 | $106 | $270 |
| Heart muscle strain imaging | 21 | $29 | $73 |
| Critical care, first 30-74 min | 21 | $174 | $485 |
| External shock to heart to regulate heart beat | 17 | $87 | $245 |
| Ultrasonic guidance for blood vessel access | 16 | $12 | $46 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 15 | $78 | $196 |
| Ultrasound of both sides of head and neck blood flow | 15 | $149 | $370 |
| Ultrasound of leg arteries or artery grafts | 14 | $182 | $465 |
| Office visit, established patient (20-29 min) | 14 | $67 | $180 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $17 | $40 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $11 | $30 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $79 | $211 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $13 | $35 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $2 | $46 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 11 | $147 | $365 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for internal medicine in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lishmanov is a clinical cardiology specialist, with above-average Medicare volume (top 23% in FL), and high industry engagement (low-engagement, top 3%), with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lishmanov experienced with office visit, established patient (30-39 min)?
Does Dr. Lishmanov receive payments from pharmaceutical companies?
How do Dr. Lishmanov's costs compare to other internal medicines in Hudson?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology